Clamikalant sodium

N/A

Report date: 2022/02/21 14:21:27
NME

Base Information

Drug NameClamikalant sodium
Drug Alias NameClamikalantum氯米卡兰氯米卡兰钠HMR-1098HMR-1883 (free base)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockersVoltage-gated potassium channel blockers
TargetsPotassium channelVoltage-gated potassium channel
Therapy Area/IndicationsMyocardial InfarctionVentricular Arrhythmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsMyocardial InfarctionVentricular Arrhythmia

Other Information

ATC CodeN/A
Related LinksN/A